Brief: Gain Therapeutics’ GT-02287 Completely Restores Motor Function In Mouse Models Of Parkinson’s Disease
06/02/2024 14:13
Feb 6 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS’ GT-02287 COMPLETELY RESTORES MOTOR
FUNCTION
IN MOUSE MODELS OF PARKINSON’S DISEASE
Source text for Eikon: ID:nGNX3R42R1
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall